SIMERGENT, LLC

OKLAHOMA CITY, OK · Medtech · Private

Faraday™ APD (automated peritoneal dialysis) device that admixes custom dialysate solutions from multiple input fluids to enable personalized sodium and dextrose concentrations

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · simergent.com

Sector
Medtech
Headquarters
OKLAHOMA CITY, OK
Latest Form D
$7.8M, May 2024
Total capital
$9.7M
Federal grants
$1.9M
3 awards · 2017–2022
Rank in peer group#95 of 477
Private capital raised
$7.8M
1 Form D · last May 2024
29 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
6
6 pending · first 2020
Rank in peer group#49 of 477

Capital timeline

20172018201920202021202220232024FEDERAL ↑EQUITY ↓Cumulative $9.7M$219K$831K$840K1st Form D$7.8M
2017201920212023FEDERAL ↑EQUITY ↓Cumulative $9.7M$219K$831K$840K1st Form D$7.8M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$7.8M
  • Federal grantHealth and Human S · Phase II · Faraday, a Novel Automated Peritoneal Dialysis Device with Dialysate Customization$840K
  • Federal grantHealth and Human S · Phase II · Faraday, a Novel Automated Peritoneal Dialysis Device with Dialysate Customization$831K
  • Federal grantHealth and Human S · Phase I · Faraday, a Novel Automated Peritoneal Dialysis Device with Dialysate Customization$219K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

80months

from SIMERGENT, LLC’s first federal award to its first private round.

First federal award · Sep 2017
Health and Human S · $219K
First Form D · May 2024
$7.8M · 1st Form D
Awards before first raise
3 awards

An association in public records, not a cause or a prediction.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grants#95 · top 20%
  • Granted patents#49 · top 10%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Steve J LindoResearcherExecutive Officer, DirectorLinked by 5 patents · $1.9M in grants as PI
  • Meredith J WilkersonDirectorNamed in SEC Form D filings
  • Michael J RohlederExecutive Officer, DirectorNamed in SEC Form D filings
  • Rick J PendergraftExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 6 granted of 12
Show all 12 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .